D. Carrle

Honokiol induces apoptosis and autophagy via the ROS/ERK1/2 signaling pathway in human osteosarcoma cells in vitro and in vivo

Solitary skeletal osteosarcoma recurrence. Findings from the Cooperative Osteosarcoma Study Group

Survival after recurrent osteosarcoma: Data from 3 European Osteosarcoma Intergroup (EOI) randomized controlled trials

Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis

Osteosarcoma: Review of the Past, Impact on the Future. The American Experience

Hepatocellular carcinoma

Liquid biopsy: monitoring cancer-genetics in the blood

Review of mifamurtide in the treatment of patients with osteosarcoma

153Samarium-EDTMP administration followed by hematopoietic stem cell support for bone metastases in osteosarcoma patients

Sarcoma in the Young Adult Population: An International View

Update on Targets and Novel Treatment Options for High-Grade Osteosarcoma and Chondrosarcoma

Incidence of Sarcoma Histotypes and Molecular Subtypes in a Prospective Epidemiological Study with Central Pathology Review and Molecular Testing

Interdependent IL-7 and IFN-γ signalling in T-cell controls tumour eradication by combined α-CTLA-4+α-PD-1 therapy

Kaempferol induced apoptosis via endoplasmic reticulum stress and mitochondria‐dependent pathway in human osteosarcoma U‐2 OS cells

A Review on the Dietary Flavonoid Kaempferol

Osteosarcoma

Osteosarcoma in very young children

Osteosarcoma treatment – Where do we stand? A state of the art review

Osteosarcoma: The COSS Experience

Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trials

An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage

Impact of close surgical margin on local recurrence and survival in osteosarcoma

Histone deacetylase inhibition sensitizes osteosarcoma to heavy ion radiotherapy

Combination immunotherapy with α-CTLA-4 and α-PD-L1 antibody blockade prevents immune escape and leads to complete control of metastatic osteosarcoma

Knockdown of galectin-1 suppresses the growth and invasion of osteosarcoma cells through inhibition of the MAPK/ERK pathway

Long-term results of the Spanish Protocol SO-95 for the treatment of non-metastatic high-grade osteosarcoma of the extremities in children

Improving Paclitaxel Delivery:In VitroandIn VivoCharacterization of PEGylated Polyphosphoester-Based Nanocarriers

Mifamurtide in metastatic and recurrent osteosarcoma: A patient access study with pharmacokinetic, pharmacodynamic, and safety assessments

Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release

Nanotechnology for Multimodal Synergistic Cancer Therapy

Natural product and natural product derived drugs in clinical trials

Osteosarcoma: Current Treatment and a Collaborative Pathway to Success

Kaempferol: A Key Emphasis to Its Anticancer Potential

Second and Subsequent Recurrences of Osteosarcoma: Presentation, Treatment, and Outcomes of 249 Consecutive Cooperative Osteosarcoma Study Group Patients

Current strategies of chemotherapy in osteosarcoma

Osteosarcoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

Osteosarcoma Lung Metastases Detection and Principles of Multimodal Therapy

The influence of tumor- and treatment-related factors on the development of local recurrence in osteosarcoma after adequate surgery. An analysis of 1355 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols

Bone Tumors in Adolescents and Young Adults

Pan-European Sarcoma Trials: Moving Forward in a Climate of Increasing Economic and Regulatory Pressure